217 related articles for article (PubMed ID: 32594588)
1. Interplay between perivascular and perineuronal extracellular matrix remodelling in neurological and psychiatric diseases.
Ulbrich P; Khoshneviszadeh M; Jandke S; Schreiber S; Dityatev A
Eur J Neurosci; 2021 Jun; 53(12):3811-3830. PubMed ID: 32594588
[TBL] [Abstract][Full Text] [Related]
2. Extracellular matrix degradation by metalloproteinases and central nervous system diseases.
Lukes A; Mun-Bryce S; Lukes M; Rosenberg GA
Mol Neurobiol; 1999 Jun; 19(3):267-84. PubMed ID: 10495107
[TBL] [Abstract][Full Text] [Related]
3. Looking Inside the Matrix: Perineuronal Nets in Plasticity, Maladaptive Plasticity and Neurological Disorders.
De Luca C; Papa M
Neurochem Res; 2016 Jul; 41(7):1507-15. PubMed ID: 26935742
[TBL] [Abstract][Full Text] [Related]
4. Crosstalk between glia, extracellular matrix and neurons.
Song I; Dityatev A
Brain Res Bull; 2018 Jan; 136():101-108. PubMed ID: 28284900
[TBL] [Abstract][Full Text] [Related]
5. The role of TIMPs in regulation of extracellular matrix proteolysis.
Arpino V; Brock M; Gill SE
Matrix Biol; 2015; 44-46():247-54. PubMed ID: 25805621
[TBL] [Abstract][Full Text] [Related]
6. Expression of extracellular matrix molecules, MMPs and TIMPs in alveolar bone, cementum and periodontal ligaments during rat tooth eruption.
Maruya Y; Sasano Y; Takahashi I; Kagayama M; Mayanagi H
J Electron Microsc (Tokyo); 2003; 52(6):593-604. PubMed ID: 14756248
[TBL] [Abstract][Full Text] [Related]
7. Regulation of ovarian extracellular matrix remodelling by metalloproteinases and their tissue inhibitors: effects on follicular development, ovulation and luteal function.
Smith MF; McIntush EW; Ricke WA; Kojima FN; Smith GW
J Reprod Fertil Suppl; 1999; 54():367-81. PubMed ID: 10692869
[TBL] [Abstract][Full Text] [Related]
8. Extracellular matrix inflammation in vascular cognitive impairment and dementia.
Rosenberg GA
Clin Sci (Lond); 2017 Mar; 131(6):425-437. PubMed ID: 28265034
[TBL] [Abstract][Full Text] [Related]
9. Targeting the neural extracellular matrix in neurological disorders.
Soleman S; Filippov MA; Dityatev A; Fawcett JW
Neuroscience; 2013 Dec; 253():194-213. PubMed ID: 24012743
[TBL] [Abstract][Full Text] [Related]
10. Extracellular matrix metalloproteinase inducer shows active perivascular cuffs in multiple sclerosis.
Agrawal SM; Williamson J; Sharma R; Kebir H; Patel K; Prat A; Yong VW
Brain; 2013 Jun; 136(Pt 6):1760-77. PubMed ID: 23687119
[TBL] [Abstract][Full Text] [Related]
11. Roles of an extracellular matrix (ECM) receptor and ECM processing enzymes in demyelinating canine distemper encephalitis.
Alldinger S; Gröters S; Miao Q; Fonfara S; Kremmer E; Baumgärtner W
Dtsch Tierarztl Wochenschr; 2006 Apr; 113(4):151-2, 154-6. PubMed ID: 16716051
[TBL] [Abstract][Full Text] [Related]
12. Activation of brain endothelial cells by interleukin-1 is regulated by the extracellular matrix after acute brain injury.
Summers L; Kangwantas K; Rodriguez-Grande B; Denes A; Penny J; Kielty C; Pinteaux E
Mol Cell Neurosci; 2013 Nov; 57():93-103. PubMed ID: 24161715
[TBL] [Abstract][Full Text] [Related]
13. Microvascular damage, neuroinflammation and extracellular matrix remodeling in Col18a1 knockout mice as a model for early cerebral small vessel disease.
Khoshneviszadeh M; Henneicke S; Pirici D; Senthilnathan A; Morton L; Arndt P; Kaushik R; Norman O; Jukkola J; Dunay IR; Seidenbecher C; Heikkinen A; Schreiber S; Dityatev A
Matrix Biol; 2024 Apr; 128():39-64. PubMed ID: 38387749
[TBL] [Abstract][Full Text] [Related]
14. Differential regulation of tissue inhibitor of metalloproteinase mRNA expression in response to intracranial injury.
Jaworski DM
Glia; 2000 Apr; 30(2):199-208. PubMed ID: 10719361
[TBL] [Abstract][Full Text] [Related]
15. Role of Matrix Metalloproteinases in Degenerative Kidney Disorders.
Narula S; Tandon C; Tandon S
Curr Med Chem; 2018; 25(15):1805-1816. PubMed ID: 29210632
[TBL] [Abstract][Full Text] [Related]
16. Interplay of angiotensin II and angiotensin(1-7) in the regulation of matrix metalloproteinases of human cardiocytes.
Pan CH; Wen CH; Lin CS
Exp Physiol; 2008 May; 93(5):599-612. PubMed ID: 18296491
[TBL] [Abstract][Full Text] [Related]
17. The tetrapartite synapse in neuropsychiatric disorders: Matrix metalloproteinases (MMPs) as promising targets for treatment and rational drug design.
Chaves Filho AJM; Mottin M; Lós DB; Andrade CH; Macedo DS
Biochimie; 2022 Oct; 201():79-99. PubMed ID: 35931337
[TBL] [Abstract][Full Text] [Related]
18. Expression of matrix metalloproteinases and their tissue inhibitor during viral encephalitis.
Zhou J; Marten NW; Bergmann CC; Macklin WB; Hinton DR; Stohlman SA
J Virol; 2005 Apr; 79(8):4764-73. PubMed ID: 15795262
[TBL] [Abstract][Full Text] [Related]
19. Matrix metalloproteinases and diseases of the central nervous system with a special emphasis on ischemic brain.
Gasche Y; Soccal PM; Kanemitsu M; Copin JC
Front Biosci; 2006 May; 11():1289-301. PubMed ID: 16368516
[TBL] [Abstract][Full Text] [Related]
20. Extracellular matrix remodelling in human aortic valve disease: the role of matrix metalloproteinases and their tissue inhibitors.
Fondard O; Detaint D; Iung B; Choqueux C; Adle-Biassette H; Jarraya M; Hvass U; Couetil JP; Henin D; Michel JB; Vahanian A; Jacob MP
Eur Heart J; 2005 Jul; 26(13):1333-41. PubMed ID: 15827062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
